NeuroSense Therapeutics Receives Japanese Patent Grant for PrimeC Novel Composition
Go back to NeuroSense Therapeutics Receives Japanese Patent Grant for PrimeC Novel Composition| (NASDAQ: NRSN) | Delayed: 0.40 +0.02 (5.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.38 | 52 Week High | $ | |||
| Open | $0.40 | 52 Week Low | $ | |||
| Day High | $0.50 | P/E | N/A | |||
| Day Low | $0.25 | EPS | $ | |||
| Volume | 1,456,039 | |||||
| (NASDAQ: NRSNW) | Delayed: 0.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.05 | 52 Week High | $ | |||
| Open | $0.05 | 52 Week Low | $ | |||
| Day High | $0.05 | P/E | N/A | |||
| Day Low | $0.05 | EPS | $ | |||
| Volume | 6 | |||||
